What the pulmonary specialist should know about the new inhalation therapies

• Published in: The European respiratory journal Vol. 37; no. 6; pp. 1308 - 1417
• Main Authors: Laube, B.L., Janssens, H.M., de Jongh, F.H.C., Devadason, S.G., Dhand, R., Diot, P., Everard, M.L., Horvath, I., Navalesi, P., Voshaar, T., Chrystyn, H.
• Format: Journal Article
• Language: English
• Published: Leeds Maney 01.06.2011
• Subjects: Acquired Immunodeficiency Syndrome - drug therapy; Administration, Inhalation; Advisory Committees - standards; Aged; Aged, 80 and over; Asthma - drug therapy; Biological and medical sciences; Child; Child, Preschool; Cystic Fibrosis - drug therapy; Delivery. Postpartum. Lactation; Familial Primary Pulmonary Hypertension; Gynecology. Andrology. Obstetrics; Humans; Hypertension, Pulmonary - drug therapy; Lung Diseases - drug therapy; Medical sciences; Nebulizers and Vaporizers; Physician-Patient Relations; Pneumology; Pulmonary Disease, Chronic Obstructive - drug therapy; Pulmonary Medicine - standards; Respiration, Artificial - methods; Respiratory Therapy - standards; inhalation therapy; pulmonary delivery; Treatment; Lung; Delivery; Technique; inhalation treatment; Inhalation technique; Inhalation; Pneumology

A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was facilitated by the European Respiratory Society (ERS) and the International Society for Aerosols in Medicine (ISAM), in order to draw up a consensus statement with clear, up-to-date recommendations that enabl...